Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Victrex Q3 revenues tick higher but Medical still hit by destocking

(Sharecast News) - Polymer maker Victrex reported volume and revenue growth for the third quarter on Thursday, but cautioned over difficult trading at its medical segment. In the period from 1 April to 30 June, group volumes rose 20% on the same period a year earlier to 979 tonnes, while revenue was 2% higher at £74m.

Victrex said average selling prices during the quarter reflected sales mix and the continued improvement in VAR (Value Added Resellers), offset by a softer performance from the medical segment.

In the medical division, Victrex said the impact of customer destocking continued into the third quarter, in line with its guidance.

Year to date, group revenue was down 9% at £213.3m. This reflects the softer first half year and lower Medical revenues. Meanwhile, volumes were down 2% at 2,716 tonnes.

Chief executive Jakob Sigurdsson said: "With continued momentum in some end markets, we remain focused on our goal of a better second half year. However, high inventory levels and industry destocking amongst major medical device customers continue to be challenging for our Medical business. At this stage, Medical performance is tracking lower than our expectations for the second half year.

"On a full year basis, our volume guidance is unchanged and we continue to expect low to mid single digit volume growth. At a profit level, destocking in Medical and ongoing lower asset utilisation continue to be headwinds, with currency rates starting to move adversely in the second half. Unless Medical improves above current run-rates, the opportunity to deliver a slightly better PBT performance in H2 2024, versus H2 2023 - in line with our previous guidance - will be challenging. Cost discipline remains strong."

Share this article

Related Sharecast Articles

Apollo to buy IGT Gaming and Everi in $6.3bn deal
(Sharecast News) - Apollo Global Management has agreed to buy International Game Technology's gaming and digital business - IGT Gaming - and gambling machines firm Everi Holdings in a $6.3bn cash deal.
3M comfortably beats expectations for Q2 revenue, earnings
(Sharecast News) - American industrial conglomerate 3M announced a strong set of second-quarter results on Friday, comfortably beating market expectations as it narrowed its guidance for the full-year towards the top end of its previous expectations.
Law Debenture delivers 'solid' overall first-half performance
(Sharecast News) - Law Debenture Corporation reported a robust first-half performance in both its investment and independent professional services (IPS) business on Friday.
GCP Infrastructure reports slight decrease in NAV per share
(Sharecast News) - GCP Infrastructure Investments said in an update on Friday that its unaudited net asset value per share was 107.58p as at 30 June, a slight decrease from 107.62p at the end of March.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.